Scaling Manufacturing of CAR-Neutrophils to Enhance Persistence & Overcome Exhaustion

• Explore scalable processes for producing CAR-engineered neutrophils with consistent quality and functionality
• Discuss how optimised culture and differentiation conditions prevent exhaustion and extend therapeutic lifespan
• Highlight how CAR-neutrophil manufacturing can enable durable, off-the-shelf solutions for solid tumour treatment

Speakers:

Mark Exley

Chief Scientific Officer

Lift Biosciences